These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 28786791)

  • 21. Latent tuberculous screening of recent migrants attending language classes: a cohort study and cost analysis.
    Usdin M; Dedicoat M; Gajraj R; Harrison P; Kaur H; Duffield K; Walker CL; Akram Y; Aiyedun V; Mohamed H; Zenner D
    Int J Tuberc Lung Dis; 2017 Feb; 21(2):175-180. PubMed ID: 28234081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.
    Campbell JR; Johnston JC; Cook VJ; Sadatsafavi M; Elwood RK; Marra F
    Emerg Infect Dis; 2019 Apr; 25(4):661-671. PubMed ID: 30882302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric tuberculosis immigration screening in high-immigration, low-incidence countries.
    Alvarez GG; Clark M; Altpeter E; Douglas P; Jones J; Paty MC; Posey DL; Chemtob D
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1530-7. PubMed ID: 21144237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for infectious diseases among newly arrived migrants in EU/EEA countries--varying practices but consensus on the utility of screening.
    Kärki T; Napoli C; Riccardo F; Fabiani M; Dente MG; Carballo M; Noori T; Declich S
    Int J Environ Res Public Health; 2014 Oct; 11(10):11004-14. PubMed ID: 25337945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013.
    Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27039665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
    Li J; Yip BHK; Leung C; Chung W; Kwok KO; Chan EYY; Yeoh E; Chung P
    PLoS One; 2018; 13(1):e0189531. PubMed ID: 29293514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivering multi-disease screening to migrants for latent TB and blood-borne viruses in an emergency department setting: A feasibility study.
    Hargreaves S; Nellums LB; Johnson C; Goldberg J; Pantelidis P; Rahman A; Friedland FMedSci JS
    Travel Med Infect Dis; 2020; 36():101611. PubMed ID: 32126293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data.
    Kawatsu L; Uchimura K; Ohkado A
    BMC Infect Dis; 2021 Jan; 21(1):42. PubMed ID: 33422003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommendations for the screening of paediatric latent tuberculosis infection in indigenous communities: a systematic review of screening strategies among high-risk groups in low-incidence countries.
    Faust L; McCarthy A; Schreiber Y
    BMC Public Health; 2018 Aug; 18(1):979. PubMed ID: 30081879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methodological considerations for economic modelling of latent tuberculous infection screening in migrants.
    Shedrawy J; Siroka A; Oxlade O; Matteelli A; Lönnroth K
    Int J Tuberc Lung Dis; 2017 Sep; 21(9):977-989. PubMed ID: 28826446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculosis screening for prospective migrants to high-income countries: systematic review of policies.
    Garner-Purkis A; Hine P; Gamage A; Perera S; Gulliford MC
    Public Health; 2019 Mar; 168():142-147. PubMed ID: 30771630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial.
    Burman M; Copas A; Zenner D; Hickson V; Gosce L; Trathen D; Ashcroft R; Martineau AR; Abubakar I; Griffiths C; Kunst H
    BMC Public Health; 2019 Nov; 19(1):1598. PubMed ID: 31783742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program.
    Wingate LT; Coleman MS; de la Motte Hurst C; Semple M; Zhou W; Cetron MS; Painter JA
    BMC Public Health; 2015 Dec; 15():1201. PubMed ID: 26627449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.
    Rustage K; Lobe J; Hayward SE; Kristensen KL; Margineanu I; Stienstra Y; Goletti D; Zenner D; Noori T; Pareek M; Greenaway C; Friedland JS; Nellums LB; Hargreaves S;
    Lancet Infect Dis; 2021 Dec; 21(12):1701-1712. PubMed ID: 34363771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study.
    Berrocal-Almanza LC; Harris R; Lalor MK; Muzyamba MC; Were J; O'Connell AM; Mirza A; Kon OM; Lalvani A; Zenner D
    Lancet Infect Dis; 2019 Nov; 19(11):1191-1201. PubMed ID: 31471131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptability of latent tuberculosis testing of migrants in a college environment in England.
    Walker CL; Duffield K; Kaur H; Dedicoat M; Gajraj R
    Public Health; 2018 May; 158():55-60. PubMed ID: 29567507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Country differences and determinants of yield in programmatic migrant TB screening in four European countries.
    Menezes D; Zenner D; Aldridge R; Anderson SR; de Vries G; Erkens C; Marchese V; Matteeli A; Muzyamba M; Nederby-Öhd J; van Rest J; Spruijt I; Were J; Lönnroth K; Abubakar I; Cobelens F
    Int J Tuberc Lung Dis; 2022 Oct; 26(10):942-948. PubMed ID: 36163670
    [No Abstract]   [Full Text] [Related]  

  • 38. Tuberculosis, focussed tools and the right schools: estimated impact and cost of a targeted student screening programme for tuberculosis infection.
    Sawka A; Geake J; Stapledon R; Barry S
    Intern Med J; 2023 Jun; 53(6):978-984. PubMed ID: 35289041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of the latent tuberculosis screening program for migrants in Stockholm Region.
    Shedrawy J; Deogan C; Öhd JN; Hergens MP; Bruchfeld J; Jonsson J; Siroka A; Lönnroth K
    Eur J Health Econ; 2021 Apr; 22(3):445-454. PubMed ID: 33559787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breaking the barriers: Migrants and tuberculosis.
    Sotgiu G; Dara M; Centis R; Matteelli A; Solovic I; Gratziou C; Rendon A; Battista Migliori G
    Presse Med; 2017 Mar; 46(2 Pt 2):e5-e11. PubMed ID: 28256381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.